SCHEMBL7426089

SCHEMBL7426089

COc1ccc(Br)cc1O[CH]c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.49
CYP1A2 P05177 2/20 0.49
CYP1B1 Q16678 2/20 0.49
APP P05067 1/20 0.42
TRPA1 O75762 1/20 0.42
NFE2L2 Q16236 1/20 0.42
TUBB1 Q9H4B7 3/20 0.41
CYP19A1 P11511 1/20 0.41
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41
TUBA4A P68366 2/20 0.41
TUBB4B P68371 2/20 0.41
TUBB3 Q13509 2/20 0.41
TUBB2A Q13885 2/20 0.41
TUBB8 Q3ZCM7 2/20 0.41
TUBA3E Q6PEY2 2/20 0.41
TUBA1A Q71U36 2/20 0.41
TUBA1C Q9BQE3 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5546522 0.81 CYP1A1 (0.57) CYP1A1CYP1A2CYP1B1TRPA1NFE2L2
SCHEMBL5547846 0.80 CA1 (0.56) CYP1A1CYP1A2CYP1B1TRPA1NFE2L2
SCHEMBL5540402 0.78 SLC6A4 (0.42) LMNANPC1RAB9AMAPTALOX12
SCHEMBL20509 0.75 CA2 (0.56) CYP1A2APPTSHRMAPTPOLB
SCHEMBL29419589 0.75 CA2 (0.56) CYP1A2APPTSHRMAPTPOLB
SCHEMBL14725300 0.75 TSHR (0.46) APPMAOBLMNATSHRMEN1
SCHEMBL130149 0.75 APP (0.43) APPTUBB1TUBB4ATUBBTUBA3C
SCHEMBL5542361 0.75 CYP1A1 (0.57) CYP1A1CYP1A2CYP1B1TRPA1NFE2L2
SCHEMBL1256865 0.73 CA2 (0.54) CYP1A2APPTSHRMAPTPOLB
SCHEMBL5607372 0.73 CA2 (0.52) CYP1A1CYP1A2CYP1B1APPCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002070469-A2 SELECTIVE PDE3B INHIBITORS AND USE OF THE SAME IN THERAPY ICOS CORPORATION (US) 2002-09-12 WO disclosed